mRNA Vaccines Beyond COVID-19 What’s Next for Infectious Diseases Abstract Messenger RNA vaccine technology came to global prominence during the COVID 19 pandemic, when rapid design, large scale manufacturing, and emergency authorization demonstrated the practical viability of this platform. Unlike traditional vaccines that rely on attenuated pathogens,
Tag: Infectious diseases
Mpox and Other Zoonoses: Are We Prepared for the Next Spillover?
Flu Outbreaks And Crisis Management Solutions
Flu Outbreaks And Crisis Management Solutions Overview Effective crisis learning is crucial for enhancing crisis management strategies. By reflecting on past public health crises, researchers and practitioners can gain valuable insights for future crisis readiness, particularly in managing critical risks and threats to public health and safety. Existing research on infectious disease
